SCHEMBL5269962

SCHEMBL5269962

O=C(O)NC1CCC(n2nnnc2C(F)(F)F)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TSHR P16473 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
DPP4 P27487 1/20 0.36
HSD11B1 P28845 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ALDH1A1 P00352 5/20 0.34
MAPK13 O15264 2/20 0.34
SMYD3 Q9H7B4 1/20 0.33
HCAR3 P49019 1/20 0.33
GLA P06280 1/20 0.32
TACR1 P25103 1/20 0.32
HDAC4 P56524 1/20 0.32
CRHR1 P34998 1/20 0.32
PKM P14618 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22722036 0.88 MEN1 (0.41) MEN1KMT2ATSHRNPSR1DPP4
SCHEMBL1973468 0.81 MEN1 (0.38) MEN1KMT2AHSD11B1L3MBTL1ALDH1A1
SCHEMBL1973469 0.81 MEN1 (0.38) MEN1KMT2AHSD11B1L3MBTL1ALDH1A1
SCHEMBL22721991 0.77 MEN1 (0.37) MEN1KMT2ATSHRNPSR1HSD11B1
SCHEMBL22722020 0.77 MEN1 (0.37) MEN1KMT2ATSHRNPSR1HSD11B1
SCHEMBL12513277 0.77 MEN1 (0.37) MEN1KMT2ATSHRNPSR1HSD11B1
SCHEMBL5031989 0.72 CCR2 (0.34) MEN1KMT2ACYP2D6
SCHEMBL12437201 0.70 JAK2 (0.42) MEN1KMT2ATSHRHSD11B1L3MBTL1
SCHEMBL1969836 0.69 HSD11B1 (0.41) HSD11B1L3MBTL1ALDH1A1CYP2C19
SCHEMBL13225927 0.65 TSHR (0.37) MEN1KMT2ATSHRNPSR1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1656138-A4 SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL MYERS SQUIBB CO (US) 2007-04-18 EP disclosed
EP-1656138-A2 SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Company (US) 2006-05-17 EP disclosed
WO-2005020899-A2 SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2005-03-10 WO disclosed